Research articles

Medical research scientists are working around Australia and the globe to better understand neurological conditions and their causes, seeking new or better treatments and ultimately, cures. Here are details of current research projects and exciting discoveries in the field of neurological research.

MSWA recommends that you discuss any research results, or new treatments mentioned, with your neurologist; as they know your individual circumstances and can provide personalised advice.

Cancer drug to be tested to treat motor neuron disease in new Australian clinical trial

MND clinical trial of cancer drug, monepantel (MPL), is set to begin later this month. The tablets are designed in a particular shape and size to help MND patients swallow them and reach specific blood drug levels targeted for this disease.

Read PharmAust's article

Effectiveness of yoga therapy for migraine: A meta-analysis of randomized controlled studies

Current evidence is insufficient for routine clinical use of yoga therapy for migraine. Several studies have explored the efficacy of yoga therapy for migraine patients, but the results are conflicting.

Read ScienceDirect's article

Trial of Metformin-Clemastine Combo Enrolls First Patient

The first participant has been enrolled in a new clinical trial that is testing whether an antihistamine in combination with a diabetes medication might promote the repair of the myelin sheath in people with multiple sclerosis (MS).

Read Multiple Sclerosis News Today's article

MSA publishes MS Nurses Report

MSWA collaborated with MSA and MS societies around Australia to put together this important research on the access and impact MS nurse care has on health outcomes of patient.

Read MS Australia Nurses Report

Motor Neurone Disease breakthrough patient trial shows impressive clinical results

A new drug delays motor neurone disease progression and improves cognitive and clinical symptoms according to recently announced trial results.

Read The Florey Institute's article

Early implementation of intended exercise improves quality of life in Parkinson’s disease patients

Recent data has shown that regular exercise may ameliorate motor symptoms in Parkinson’s disease (PD). This study aims to investigate how intended exercise impacts motor and non-movement symptoms of PD.

Read the article

MS and COVID-19

Most people with MS who develop COVID-19 have mild to moderate symptoms and will not develop serious complications which require hospital care. However, they may still experience long-term effects due to COVID-19. This study was designed to find out how well people with MS recover from mild to moderate COVID-19 and the factors that influence recovery.

Read Multiple Sclerosis Trust's article

Australian researchers discover how immune cell ‘spider webs’ may lead to autoimmunity

An MS Australia-supported study has discovered how NETs might be involved in the damaging immune response seen in some immune-mediated conditions, such as multiple sclerosis (MS).

Read MS Australia's article

People with Parkinson's who eat a diet rich in flavonoids may live longer

A recent study published in the American Academy of Neurology suggests that people who did something as simple as including three or more servings per week of common foods like red berries, apples, orange juice and red wine may have improved chances of living longer,” said study author Xiang Gao, MD, PhD, of The Pennsylvania State University in University Park.

Read Shake It Up Australia Foundation's article

An Epstein-Barr Virus Primer for MS Patients

Several studies over the past few years suggested an EBV-MS connection, and that link might be in memory B-cells. When EBV is in the body in its dormant form, it situates itself inside those B-cells. Some of our disease-modifying therapies are designed to target B-cells, reducing their numbers or preventing them from traveling into the central nervous system.

Read MS News Today's article

Get in touch

If you would like more information about specific research, email us at

Click here to read the latest edition of Vitality – MSWA's monthly e-newsletter covering the latest articles relating to research, medical advancements and general wellbeing for people living with MS and other neurological conditions.